.Merck trumps profits assumptions, increases purchases expectation on powerful demand for best drugs like Keytruda CNBCMerck & Co. (MRK United States) Beats Profit Estimates as Keytruda Sales Growth BloombergMerck Stock: Pharma Titan Posts Sturdy Results, Yet Overview Falls Short Entrepreneur's Company DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck defeats revenue and sales assumptions among Keytruda asset, but provides blended full-year overview MarketWatch.